H Raza Ali

Citado por

	Total	Desde 2019
Citas	10156	7164
Índice h	37	32
Índice i10	47	46

1400

700

350

1050

201220132014201520162017201820192020202120222023202495 189 204 422 582 662 753 847 1089 1323 1384 1292 1213

Acceso público

Ver todo

47 artículos

2 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Carlos CaldasUniversity of CambridgeDirección de correo verificada de cruk.cam.ac.uk
Suet Feung ChinUniversity of CambridgeDirección de correo verificada de cam.ac.uk
Paul PharoahCedars-Sinai Medical CenterDirección de correo verificada de cshs.org
Oscar M RuedaMRC Investigator, Programme Leader, MRC-Biostatistics Unit. University of CambridgeDirección de correo verificada de mrc-bsu.cam.ac.uk
Samuel AparicioUBC, BC Cancer Agency, VancouverDirección de correo verificada de bccrc.ca
Mark J DunningUniversity of SheffieldDirección de correo verificada de sheffield.ac.uk
Christina CurtisStanford UniversityDirección de correo verificada de stanford.edu
Jason CarrollUniversity of CambridgeDirección de correo verificada de cruk.cam.ac.uk
Janet DunnUniversity of WarwickDirección de correo verificada de warwick.ac.uk
Alejandra BrunaAssociate ScientistDirección de correo verificada de cruk.cam.ac.uk
Bernd BodenmillerDual Professor University of Zurich and ETH Zurich. Director, Department of Quantitative BiomedicineDirección de correo verificada de uzh.ch
Vito RT ZanotelliUniversity Children's Hospital Zurich/University of ZurichDirección de correo verificada de kispi.uzh.ch
Maurizio Callari, PhDFondazione MichelangeloDirección de correo verificada de fondazionemichelangelo.org
Florian MarkowetzCancer Research UK Cambridge InstituteDirección de correo verificada de cruk.cam.ac.uk
Jana R FischerPhD student, University of ZurichDirección de correo verificada de uzh.ch
Hartland Warren JacksonInvestigator, Lunenfeld-Tanenbaum Research Institute, Mount Sinai HospitalDirección de correo verificada de lunenfeld.ca
Suraj MenonDirector of Bioinformatics, Artios PharmaDirección de correo verificada de artiospharma.com
Torsten NielsenProfessor of Pathology, University of British ColumbiaDirección de correo verificada de mail.ubc.ca
Rory StarkAltos LabsDirección de correo verificada de starkhome.com
Simak AliImperial College LondonDirección de correo verificada de imperial.ac.uk

Seguir

H Raza Ali

Group Leader, CRUK Cambridge Institute, University of Cambridge

Dirección de correo verificada de cruk.cam.ac.uk - Página principal

Cancer Pathology Breast Cancer Digital Pathology Imaging Mass Cytometry


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ... Nature 481 (7381), 389-393, 2012	2125	2012
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of oncology 25 (8), 1536-1543, 2014	856	2014
The single-cell pathology landscape of breast cancer HW Jackson, JR Fischer, VRT Zanotelli, HR Ali, R Mechera, SD Soysal, ... Nature 578 (7796), 615-620, 2020	735	2020
Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas PLoS medicine 13 (12), e1002194, 2016	581	2016
Prognostic and predictive value of PDL1 expression in breast cancer R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ... Oncotarget 6 (7), 5449, 2014	554	2014
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 8760, 2015	529	2015
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ... Science translational medicine 4 (157), 157ra143-157ra143, 2012	479	2012
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013	415	2013
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ... Nature 567 (7748), 399-404, 2019	338	2019
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes HR Ali, SE Glont, FM Blows, E Provenzano, SJ Dawson, B Liu, L Hiller, ... Annals of Oncology 26 (7), 1488-1493, 2015	331	2015
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer HR Ali, HW Jackson, VRT Zanotelli, E Danenberg, JR Fischer, H Bardwell, ... Nature Cancer 1 (2), 163-175, 2020	264	2020
Genome-driven integrated classification of breast cancer validated in over 7,500 samples HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ... Genome biology 15, 1-14, 2014	249	2014
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4⁺ and PDPN⁺ CAFs to clinical outcome G Friedman, O Levi-Galibov, E David, C Bornstein, A Giladi, M Dadiani, ... Nature Cancer 1 (7), 692-708, 2020	232	2020
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ... Scientific reports 6 (1), 1-13, 2016	205	2016
BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells WT Khaled, S Choon Lee, J Stingl, X Chen, H Raza Ali, OM Rueda, ... Nature communications 6 (1), 5987, 2015	172	2015
Breast tumor microenvironment structures are associated with genomic features and clinical outcome E Danenberg, H Bardwell, VRT Zanotelli, E Provenzano, SF Chin, ... Nature genetics 54 (5), 660-669, 2022	163	2022
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ... EMBO molecular medicine 3 (3), 167-180, 2011	142	2011
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance HR Ali, SJ Dawson, FM Blows, E Provenzano, PD Pharoah, C Caldas Breast Cancer Research 13, 1-15, 2011	138	2011
The genomic and immune landscapes of lethal metastatic breast cancer L De Mattos-Arruda, SJ Sammut, EM Ross, R Bashford-Rogers, ... Cell reports 27 (9), 2690-2708. e10, 2019	118	2019
Spatial predictors of immunotherapy response in triple-negative breast cancer XQ Wang, E Danenberg, CS Huang, D Egle, M Callari, B Bermejo, ... Nature 621 (7980), 868-876, 2023	102	2023

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores